{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:01:17Z","timestamp":1790910077247,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2022YFA1103300"],"award-info":[{"award-number":["2022YFA1103300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clinical and Translational Medicine Research Project of Chinese Academy of Medical Sciences","award":["2023-I2M-C&T-B-107"],"award-info":[{"award-number":["2023-I2M-C&T-B-107"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-C-026"],"award-info":[{"award-number":["2022-PUMCH-C-026"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82370142"],"award-info":[{"award-number":["82370142"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00277-025-06335-9","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T03:35:02Z","timestamp":1743996902000},"page":"1515-1525","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The efficacy of immunosuppressive therapy with or without thrombopoietin receptor agonist in elderly patients with severe aplastic anemia"],"prefix":"10.1007","volume":"104","author":[{"given":"Jianping","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengkui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"issue":"4","key":"6335_CR1","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3324\/haematol.12020","volume":"93","author":"E Montan\u00e9","year":"2008","unstructured":"Montan\u00e9 E, Ib\u00e1\u00f1ez L, Vidal X et al (2008) Epidemiology of aplastic anemia: a prospective multicenter study [J]. Haematologica 93(4):518\u2013523. https:\/\/doi.org\/10.3324\/haematol.12020","journal-title":"Haematologica"},{"issue":"12","key":"6335_CR2","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.3324\/haematol.2022.280758","volume":"107","author":"ZL Xu","year":"2022","unstructured":"Xu ZL, Xu LP, Wu DP et al (2022) Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a National registry-based study [J]. Haematologica 107(12):2918\u20132927. https:\/\/doi.org\/10.3324\/haematol.2022.280758","journal-title":"Haematologica"},{"issue":"9","key":"6335_CR3","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.scib.2022.01.024","volume":"67","author":"LP Xu","year":"2022","unstructured":"Xu LP, Xu ZL, Wang SQ et al (2022) Long-term follow-up of haploidentical transplantation in relapsed\/refractory severe aplastic anemia: a multicenter prospective study [J]. Sci Bull (Beijing) 67(9):963\u2013970. https:\/\/doi.org\/10.1016\/j.scib.2022.01.024","journal-title":"Sci Bull (Beijing)"},{"issue":"16","key":"6335_CR4","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJMoa1613878","volume":"376","author":"DM Townsley","year":"2017","unstructured":"Townsley DM, Scheinberg P, Winkler T et al (2017) Eltrombopag added to standard immunosuppression for aplastic anemia [J]. N Engl J Med 376(16):1540\u20131550. https:\/\/doi.org\/10.1056\/NEJMoa1613878","journal-title":"N Engl J Med"},{"issue":"1","key":"6335_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa2109965","volume":"386","author":"R De Peffault","year":"2022","unstructured":"De Peffault R, Kulasekararaj A, Iacobelli S et al (2022) Eltrombopag added to immunosuppression in severe aplastic anemia [J]. N Engl J Med 386(1):11\u201323. https:\/\/doi.org\/10.1056\/NEJMoa2109965","journal-title":"N Engl J Med"},{"issue":"6","key":"6335_CR6","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1182\/blood-2011-12-274019","volume":"120","author":"P Scheinberg","year":"2012","unstructured":"Scheinberg P, Young NS (2012) How I treat acquired aplastic anemia [J]. Blood 120(6):1185\u20131196. https:\/\/doi.org\/10.1182\/blood-2011-12-274019","journal-title":"Blood"},{"issue":"3","key":"6335_CR7","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/bjh.19236","volume":"204","author":"A Kulasekararaj","year":"2024","unstructured":"Kulasekararaj A, Cavenagh J, Dokal I et al (2024) Guidelines for the diagnosis and management of adult aplastic anaemia: A British society for haematology guideline [J]. Br J Haematol 204(3):784\u2013804. https:\/\/doi.org\/10.1111\/bjh.19236","journal-title":"Br J Haematol"},{"issue":"17","key":"6335_CR8","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMra1413485","volume":"379","author":"NS Young","year":"2018","unstructured":"Young NS (2018) Aplastic anemia [J]. N Engl J Med 379(17):1643\u20131656. https:\/\/doi.org\/10.1056\/NEJMra1413485","journal-title":"N Engl J Med"},{"issue":"2","key":"6335_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3324\/haematol.2018.207167","volume":"104","author":"A Bacigalupo","year":"2019","unstructured":"Bacigalupo A (2019) Antithymocyte Globulin and cyclosporin: standard of care also for older patients with aplastic anemia [J]. Haematologica 104(2):215\u2013216. https:\/\/doi.org\/10.3324\/haematol.2018.207167","journal-title":"Haematologica"},{"key":"6335_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19648","author":"A Prabahran","year":"2024","unstructured":"Prabahran A, Durrani J, Coelho-Da Silva J et al (2024) Safety and efficacy of immunosuppressive therapy for elderly patients with severe aplastic anaemia [J]. Br J Haematol. https:\/\/doi.org\/10.1111\/bjh.19648","journal-title":"Br J Haematol"},{"issue":"2","key":"6335_CR11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/bmt.2012.224","volume":"48","author":"A Tichelli","year":"2013","unstructured":"Tichelli A, Marsh JC (2013) Treatment of aplastic anaemia in elderly patients aged\u2009>\u200960 years [J]. Bone Marrow Transpl 48(2):180\u2013182. https:\/\/doi.org\/10.1038\/bmt.2012.224","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"6335_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1365-2141.2008.07450.x","volume":"144","author":"P Scheinberg","year":"2009","unstructured":"Scheinberg P, Wu CO, Nunez O et al (2009) Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia [J]. Br J Haematol 144(2):206\u2013216. https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07450.x","journal-title":"Br J Haematol"},{"issue":"6","key":"6335_CR13","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1182\/blood.V70.6.1718.1718","volume":"70","author":"Incidence of aplastic","year":"1987","unstructured":"Incidence of aplastic (1987) Anemia: the relevance of diagnostic criteria. By the international agranulocytosis and aplastic anemia study [J]. Blood 70(6):1718\u20131721DOI","journal-title":"Blood"},{"issue":"1","key":"6335_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1182\/blood.V48.1.63.63","volume":"48","author":"BM Camitta","year":"1976","unstructured":"Camitta BM, Thomas ED, Nathan DG et al (1976) Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality [J]. Blood 48(1):63\u201370DOI","journal-title":"Blood"},{"issue":"2","key":"6335_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2141.1988.tb02460.x","volume":"70","author":"A Bacigalupo","year":"1988","unstructured":"Bacigalupo A, Hows J, Gluckman E et al (1988) Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party [J]. Br J Haematol 70(2):177\u2013182. https:\/\/doi.org\/10.1111\/j.1365-2141.1988.tb02460.x","journal-title":"Br J Haematol"},{"issue":"1","key":"6335_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1414799","volume":"373","author":"T Yoshizato","year":"2015","unstructured":"Yoshizato T, Dumitriu B, Hosokawa K et al (2015) Somatic mutations and clonal hematopoiesis in aplastic anemia [J]. N Engl J Med 373(1):35\u201347. https:\/\/doi.org\/10.1056\/NEJMoa1414799","journal-title":"N Engl J Med"},{"issue":"3","key":"6335_CR17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/ejh.12590","volume":"96","author":"M Chen","year":"2016","unstructured":"Chen M, Liu C, Zhuang J et al (2016) Long-term follow-up study of Porcine anti-human thymocyte Immunoglobulin therapy combined with cyclosporine for severe aplastic anemia [J]. Eur J Haematol 96(3):291\u2013296. https:\/\/doi.org\/10.1111\/ejh.12590","journal-title":"Eur J Haematol"},{"key":"6335_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.leukres.2018.01.001","volume":"65","author":"M Chen","year":"2018","unstructured":"Chen M, Liu C, Qiao X et al (2018) Comparative study of Porcine anti-human lymphocyte Immunoglobulin and rabbit anti-human thymocyte Immunoglobulin as a first-line treatment of acquired severe aplastic anemia [J]. Leuk Res 65:55\u201360. https:\/\/doi.org\/10.1016\/j.leukres.2018.01.001","journal-title":"Leuk Res"},{"issue":"6","key":"6335_CR19","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/ejh.13398","volume":"104","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Yang Y, Yang W et al (2020) Efficacy and safety of Porcine ALG compared to rabbit ATG as first-line treatment for children with acquired aplastic anemia [J]. Eur J Haematol 104(6):562\u2013570. https:\/\/doi.org\/10.1111\/ejh.13398","journal-title":"Eur J Haematol"},{"issue":"4","key":"6335_CR20","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.exphem.2014.12.002","volume":"43","author":"L Zhang","year":"2015","unstructured":"Zhang L, Jing L, Zhou K et al (2015) Rabbit antithymocyte Globulin as first-line therapy for severe aplastic anemia [J]. Exp Hematol 43(4):286\u2013294. https:\/\/doi.org\/10.1016\/j.exphem.2014.12.002","journal-title":"Exp Hematol"},{"issue":"3","key":"6335_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.7326\/0003-4819-130-3-199902020-00004","volume":"130","author":"A Tichelli","year":"1999","unstructured":"Tichelli A, Soci\u00e9 G, Henry-Amar M et al (1999) Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European group for blood and marrow transplantation severe aplastic anaemia working party [J]. Ann Intern Med 130(3):193\u2013201. https:\/\/doi.org\/10.7326\/0003-4819-130-3-199902020-00004","journal-title":"Ann Intern Med"},{"issue":"5","key":"6335_CR22","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/ajh.25081","volume":"93","author":"A Bacigalupo","year":"2018","unstructured":"Bacigalupo A, Oneto R, Schrezenmeier H et al (2018) First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: outcome of 955 patients treated 2001\u20132012 [J]. Am J Hematol 93(5):643\u2013648. https:\/\/doi.org\/10.1002\/ajh.25081","journal-title":"Am J Hematol"},{"issue":"12","key":"6335_CR23","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.leukres.2006.02.003","volume":"30","author":"SB Killick","year":"2006","unstructured":"Killick SB, Cavenagh JD, Davies JK et al (2006) Low dose antithymocyte Globulin for the treatment of older patients with aplastic anaemia [J]. Leuk Res 30(12):1517\u20131520. https:\/\/doi.org\/10.1016\/j.leukres.2006.02.003","journal-title":"Leuk Res"},{"issue":"7","key":"6335_CR24","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3760\/cma.j.issn.0253-2727.2016.07.013","volume":"37","author":"JP Li","year":"2016","unstructured":"Li JP, Yang WR, Li Y et al (2016) [Antithymocyte\/Antilymphocyte Globulin plus cyclosporine A therapy for the treatment of older patients with severe aplastic anemia] [J]. Zhonghua Xue Ye Xue Za Zhi 37(7):607\u2013610. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2016.07.013","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"6335_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27611","author":"B Fattizzo","year":"2025","unstructured":"Fattizzo B, Gurnari C, Giammarco S et al (2025) Elderly patients with aplastic anemia: treatment patterns and outcomes in the real world [J]. Am J Hematol. https:\/\/doi.org\/10.1002\/ajh.27611","journal-title":"Am J Hematol"},{"issue":"1","key":"6335_CR26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13045-021-01159-2","volume":"14","author":"XH Zhang","year":"2021","unstructured":"Zhang XH, Chen J, Han MZ et al (2021) The consensus from the Chinese society of hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update [J]. J Hematol Oncol 14(1):145. https:\/\/doi.org\/10.1186\/s13045-021-01159-2","journal-title":"J Hematol Oncol"},{"issue":"17","key":"6335_CR27","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1182\/blood-2017-09-807859","volume":"131","author":"S Giammarco","year":"2018","unstructured":"Giammarco S, Peffault De Latour R, Sica S et al (2018) Transplant outcome for patients with acquired aplastic anemia over the age of 40: has the outcome improved? [J]. Blood 131(17):1989\u20131992. https:\/\/doi.org\/10.1182\/blood-2017-09-807859","journal-title":"Blood"},{"issue":"2","key":"6335_CR28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/bjh.14225","volume":"175","author":"LP Xu","year":"2016","unstructured":"Xu LP, Wang SQ, Wu DP et al (2016) Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study [J]. Br J Haematol 175(2):265\u2013274. https:\/\/doi.org\/10.1111\/bjh.14225","journal-title":"Br J Haematol"},{"issue":"8","key":"6335_CR29","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s00277-023-05256-9","volume":"102","author":"LQ Wu","year":"2023","unstructured":"Wu LQ, Huang LF, Yang H et al (2023) Comparison of haploidentical-allogeneic hematopoietic stem cell transplantation and intensive immunosuppressive therapy for patients with severe aplastic anemia with an absolute neutrophil count of zero: a retrospective study [J]. Ann Hematol 102(8):2015\u20132023. https:\/\/doi.org\/10.1007\/s00277-023-05256-9","journal-title":"Ann Hematol"},{"issue":"3","key":"6335_CR30","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/bjh.17232","volume":"192","author":"EM Groarke","year":"2021","unstructured":"Groarke EM, Patel BA, Gutierrez-Rodrigues F et al (2021) Eltrombopag added to immunosuppression for children with treatment-na\u00efve severe aplastic anaemia [J]. Br J Haematol 192(3):605\u2013614. https:\/\/doi.org\/10.1111\/bjh.17232","journal-title":"Br J Haematol"},{"issue":"2","key":"6335_CR31","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3324\/haematol.2018.198440","volume":"104","author":"A Contejean","year":"2019","unstructured":"Contejean A, Resche-Rigon M, Tamburini J et al (2019) Aplastic anemia in the elderly: a nationwide survey on behalf of the French reference center for aplastic anemia [J]. Haematologica 104(2):256\u2013262. https:\/\/doi.org\/10.3324\/haematol.2018.198440","journal-title":"Haematologica"},{"issue":"3","key":"6335_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/10245332.2017.1375063","volume":"23","author":"S Shahrabi","year":"2018","unstructured":"Shahrabi S, Khodadi E, Saba F et al (2018) Sex chromosome changes in leukemia: cytogenetics and molecular aspects [J]. Hematology 23(3):139\u2013147. https:\/\/doi.org\/10.1080\/10245332.2017.1375063","journal-title":"Hematology"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06335-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06335-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06335-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T10:10:46Z","timestamp":1745575846000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06335-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["6335"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06335-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"29 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Blood Diseases Hospital, CAMS, and PUMC. All procedures followed were in accordance with the Helsinki Declaration of 1975, as revised in 2008.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained for each patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}